No mammalian eyes can naturally see past the visible spectral region into the infrared (IR). The visible region is often defined as 400 to 700 nm, although the human eye has a low and declining, but real, sensitivity to light out to 780 nm (and a little beyond that, if you’re willing to look at laser light intense enough to damage your eyes). The evolutionary reason for this drop in spectral sensitivity is that, for mammalian opsin-based receptors, the lower energy of IR photons would require a lower energy barrier in the opsin, which would end up boosting the relative thermal noise energy too high for practicality. 

As for artificial digital imaging, there is a technique called upconversion IR imaging, in which the imaging system uses nonlinear optics to shorten the wavelength of the IR light, allowing less-costly cameras to do the imaging. 

Now, a multidisciplinary group of researchers led by Xue and Jin Bao at the University of Science and Technology of China (Hefei, China) as well as Gang Han at the University of Massachusetts Medical School (Worcester, MA), have developed a simple way to enable mammalian vision in the near-IR out to 1000 nm, using upconversion imaging—and have tested it successfully on mice. The approach they take is quite simple: they inject photoreceptor-binding upconversion nanoparticles (pbUCNPs) into the eyes of mice so that the particles are near the retina. 

Mice who had retinal photoreceptor-binding upconversion nanoparticles (pbUCNPs, which anchor themselves to the inner and outer segments of both rods and cones) injected into their eyes showed pupil constriction when subjected to IR light at 980 nm, demonstrating that their eyes and brain had detected the IR light. In contrast, mice who had polyacrylic acid-coated upconversion nanoparticles (paaUCNPs, which did not anchor tightly to the rods and cones) injected into their eyes showed the normal visible-light pupil response, but no IR response. 

ONLY ONE INJECTION NEEDED

A single injection of nanoparticles in the mice’s eyes bestowed IR vision for up to 10 weeks with minimal side effects, allowing them to see IR light even during the day and with enough specificity to distinguish between different shapes. Mice that received the injections showed unconscious physical signs that they were detecting IR light, such as their pupils constricting, while mice injected with only the buffer solution didn’t respond to IR light (see figure). 

To test whether the mice could make sense of the IR light, the researchers set up a series of maze tasks to show the mice could see IR even in daylight conditions, simultaneously with visible light. 

The researchers believe the biointegrated nanoparticles are desirable for potential IR applications in encryption, security, and military operations. “In the future, we think there may be room to improve the technology with a new version of organic-based nanoparticles, made of FDA-approved compounds, that appear to result in even brighter infrared vision,” says Han, who notes that they will also be tailoring the IR excitation wavelength in these newer nanoparticles. 

The nanoparticle-based vision-enhancement approach could potentially be useful in civilian encryption and device identification, security, military operations, and human-machine interfaces, say the researchers, and could possibly also be used to repair visual function. 

(From:https://www.laserfocusworld.com/articles/print/volume-55/issue-04/world-news/ir-upconversion-imaging-upconversion-nanoparticles-in-eyes-enable-mice-to-see-infrared-may-work-for-humans-too.html)